Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
GLP-1 drugs are life-changing. But the science is clear: without resistance training, you lose more than just weight.
HEALTH & WELLNESS · MARCH 2026
If you’re taking a GLP-1 drug like Ozempic, Wegovy, or Mounjaro, you already know the appeal. The weight falls off. Hunger subsides. You feel like the deck is finally stacked in your favor. And this is – these are really effective drugs.
But here’s the catch: the weight you lose isn’t all fat. A significant portion can come from lean body mass, which includes muscle. Over time, without lean mass conservation strategies, this can lead to reduced strength and functional capacity.
The good news? The fix does not require hours in the gym. Short, consistent bouts of resistance movement can help preserve muscle. Here’s what the research shows.
The hidden costs of GLP-1 weight loss
Studies of semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) consistently found that 25% to 40% of the weight lost with these drugs is lean body mass — which includes muscles. The landmark STEP 1 study of semaglutide found that approximately 40% of total weight loss came from lean tissue, not fat. This is nothing.
25–40%
of GLP-1, weight loss can come from lean muscle mass, not fat
30%
potentially higher risk of osteoporosis in GLP-1 users compared to non-users
~1 in 8
Adults in the US now take a GLP-1 drug
10 min
daily strength training can significantly preserve muscle and bone
Why does this matter? Muscle plays a key role in metabolic health, strength, mobility and long-term function. Loss of lean mass can contribute to fatigue, decreased strength, and an increased risk of frailty over time.
New research: GLP-1s and bone risk
Some emerging research is investigating the potential effects of GLP-1 drugs on bone health. The results are in mixed and not final.Weight loss itself – regardless of the method – is associated with a decrease in bone density. Reduced caloric intake and lower mechanical load contribute.
Exercise, especially resistance and weight-bearing exercise, is one of the most evidence-based ways to help preserve bone density during weight loss.
Why resistance training is non-negotiable
Strength training is one of the most effective tools for preserving muscle and bone during weight loss.
A randomized clinical trial published in JAMA Network Open (2024) found that combining GLP-1 therapy with exercise resulted in better preservation of bone mineral density compared to GLP-1 therapy alone.
« It seems highly advisable to implement targeted exercise to preserve and potentially increase muscle mass in patients receiving GLP-1-based therapies. »
— Frontiers in Endocrinology, 2024
A separate case series published in PMC showed that GLP-1 users who did structured resistance training 3-5 days a week not only preserved muscle—some patients actually increased their lean mass while losing significant body fat. This is the difference between losing weight and actually changing your body composition.
The conclusion of the study: the drug leads to fat loss. You save muscle.
This is where microdose training comes in
Here’s the thing about people on GLP-1 drugs: they’re often looking for the most effective route with the least effort. This is not a criticism – it is clever. These drugs work precisely because they lower the threshold for success. Microdose training follows the same philosophy.
You don’t need a 60-minute gym session to protect your muscle mass. Research shows that short, frequent bouts of resistance exercise — even as little as 5 to 10 minutes at a time — stimulate the muscle-preserving response your body needs. A 2025 study from Edith Cowan University found that a daily 5-minute bodyweight workout helped improve strength, flexibility and mood even in people who rarely exercised.
« People taking GLP-1 drugs already have a tool for appetite and fat loss. Resistance training complements that by helping to preserve muscle. »
— Evidence-based consensus in exercise physiology research
Think of it as a pairing of two performance tools: the drug handles calorie reduction; short daily exercise keeps muscles and bones strong. Together they produce a result that neither of them can achieve alone.
What this might look like in your day
GLP-1 Friendly Microdose Resistance Movements (5–10 minutes each)
- Push-ups on a wall or push-ups on the floor (3 sets of 10–15 reps) while the coffee is brewing
- Bodyweight squats or chair squats – great for quads and glutes
- Resistance band rows or curls at your desk or in front of the TV
- Climbing stairs at a fast pace is one of the most studied activities for bone protection
- Slow, controlled seizures during a phone call
- Plank Hold (20–30 seconds) — builds core strength without the gym required
- The heel lifts while standing on the kitchen counter — protects the ankle and calf muscles
You don’t need weights. You don’t need a gym membership. You need consistency and a little effort applied in the right direction. Even three or four of these « microdoses » per week can make a significant difference in your muscle and bone health over time.
The Takeaway
GLP-1 drugs are a powerful tool. But tools work best when used correctly. The research is unequivocal: without some form of resistance exercise, you risk losing the muscle and bone density you need for a long, healthy life. And with microdose training, the bar couldn’t be lower.
Ten minutes. Several times a week. No gym necessary. Just as your drug requires very little of you each week for a big reward, so does this.
The scale only tells you part of the story. Make sure the rest of the story is good.
The research behind this article
- Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment (JAMA Network Open, 2024) — RCT of 195 adults over 52 weeks. Exercise + GLP-1 therapy preserved bone density in the hip, spine, and forearm relative to GLP-1 therapy alone, which resulted in reduced bone mineral density.
- Preservation of lean soft tissue during weight loss with GLP-1 therapies (PMC, 2025) — Case series showing GLP-1 users who combined resistance training (3–5 days/week) with adequate protein either minimized muscle loss or actually increased lean soft tissue while losing fat.
- GLP-1 may increase risk of osteoporosis, new research (AAOS/NBC News, 2026) — A large retrospective study presented at the American Academy of Orthopedic Surgeons found that GLP-1 users had approximately 30% higher rates of osteoporosis and nearly doubled their risk of bone mineral density problems over five years.
- Muscle mass and GLP-1 receptor agonists: Adaptive or maladaptive response? (Circulation, 2024) — Comprehensive review from the Journal of the American Heart Association. Semaglutide associated with lean mass loss of up to 40% of total weight lost in the STEP 1 study; emphasizes the importance of targeted lifestyle interventions.
- GLP-1s and Lean Mass: What the Research Shows (ACE Fitness, 2025) — Genetic study analysis of 800,000+ individuals confirming that while GLP-1s reduce both fat and lean mass, fat loss is more substantial. Recommends strength training 2–3 times per week and protein goals of 1.2–1.6 g/kg/day to preserve muscle.
This article is for informational purposes only and is not a substitute for professional medical advice. Always check with your doctor or medical team before changing your exercise routine while on any medication.
Fitness,Other Fitness,Uncategorized
#Ozempic #Wegovy #Heres
